FDA Releases National Antimicrobial Resistance Monitoring System Summary for 2019

The National Antimicrobial Resistance Monitoring System (NARMS) released the NARMS Integrated Summary 2019. NARMS is a national public health system that monitors pathogens in human and animal samples for resistance to antimicrobial drugs used in human and veterinary medicine. The NARMS Integrated Summary 2019 combines antimicrobial resistance data in bacteria isolated from humans (by CDC), raw retail meats (by FDA), and animals at slaughter (by USDA) to examine trends in resistance to the most important antimicrobial agents. The data from 2019 showed that 78% of Salmonella isolates collected from humans were not resistant to any of the antimicrobials. In humans, the overall resistance level remains relatively unchanged from 2018 and is in line with other data from 2006 to 2017, where 76–85% of Salmonella tested were susceptible to all antimicrobials. @ https://www.fda.gov/animal-veterinary/cvm-updates/fda-releases-narms-integrated-summary-2019?utm_medium=email&utm_source=govdelivery

 

 NARMS Integrated Summary 2019 Released
NARMS Integrated Summary 2019 Released

NARMS Integrated Summary 2019 reports on trends in antimicrobial resistance in bacterial samples isolated from humans, raw retail meats, and animals.

No comments

Leave a Reply